APO Research

APO RESEARCH · REPORT

Antigen Skin Test

Selected research

Market Outlook & Growth Opportunities

Global Antigen Skin Test Market Outlook and Growth Opportunities 2026

Market perspective

The global Antigen Skin Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antigen Skin Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antigen Skin Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antigen Skin Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antigen Skin Test market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antigen Skin Test market include BD, CorisBioconcept and Armed Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Antigen Skin Test market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antigen Skin Test and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antigen Skin Test revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Antigen Skin Test market.

Antigen Skin Test Segment by Company

BD

CorisBioconcept

Armed Group

Antigen Skin Test Segment by Type

Fungal Infection

Bacterial Infection

Parasitic Infection

Antigen Skin Test Segment by Application

Hospitals

Clinics

Antigen Skin Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antigen Skin Test status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Antigen Skin Test key companies, revenue, market share, and recent developments.

3. To split the Antigen Skin Test breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Antigen Skin Test market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antigen Skin Test significant trends, drivers, influence factors in global and regions.

6. To analyze Antigen Skin Test competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antigen Skin Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antigen Skin Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antigen Skin Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antigen Skin Test industry.

Chapter 3: Detailed analysis of Antigen Skin Test company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Antigen Skin Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Antigen Skin Test in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antigen Skin Test Industry Trends Table 2. Antigen Skin Test Industry Drivers Table 3. Antigen Skin Test Industry Opportunities and Challenges Table 4. Antigen Skin Test Industry Restraints Table 5. Global Antigen Skin Test Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antigen Skin Test Revenue Share by Company (2021-2026) Table 7. Global Antigen Skin Test Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Antigen Skin Test Key Company Manufacturing Base & Headquarters Table 9. Global Antigen Skin Test Company, Product Type & Application Table 10. Global Antigen Skin Test Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Antigen Skin Test by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Fungal Infection Table 15. Significant Companies of Bacterial Infection Table 16. Significant Companies of Parasitic Infection Table 17. Global Antigen Skin Test Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Antigen Skin Test Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Antigen Skin Test Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Antigen Skin Test Sales Value Share by Type (2021-2026) Table 21. Global Antigen Skin Test Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Clinics Table 24. Global Antigen Skin Test Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Antigen Skin Test Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Antigen Skin Test Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Antigen Skin Test Sales Value Share by Application (2021-2026) Table 28. Global Antigen Skin Test Sales Value Share by Application (2027-2032) Table 29. Global Antigen Skin Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Antigen Skin Test Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Antigen Skin Test Sales Value Share by Region (2021-2026) Table 32. Global Antigen Skin Test Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Antigen Skin Test Sales Value Share by Region (2027-2032) Table 34. Global Antigen Skin Test Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Antigen Skin Test Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Antigen Skin Test Sales Value Market Share by Country (2021-2026) Table 37. Global Antigen Skin Test Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Antigen Skin Test Sales Value Market Share by Country (2027-2032) Table 39. BD Company Information Table 40. BD Business Overview Table 41. BD Antigen Skin Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. BD Antigen Skin Test Product Portfolio Table 43. BD Recent Development Table 44. CorisBioconcept Company Information Table 45. CorisBioconcept Business Overview Table 46. CorisBioconcept Antigen Skin Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. CorisBioconcept Antigen Skin Test Product Portfolio Table 48. CorisBioconcept Recent Development Table 49. Armed Group Company Information Table 50. Armed Group Business Overview Table 51. Armed Group Antigen Skin Test Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Armed Group Antigen Skin Test Product Portfolio Table 53. Armed Group Recent Development Table 54. Research Programs/Design for This Report Table 55. Authors List of This Report Table 56. Secondary Sources Table 57. Primary Sources List of Figures Figure 1. Antigen Skin Test Product Image Figure 2. Global Antigen Skin Test Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antigen Skin Test Market Size (2021-2032) & (US$ Million) Figure 4. Global Antigen Skin Test Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Fungal Infection Image Figure 8. Bacterial Infection Image Figure 9. Parasitic Infection Image Figure 10. Global Antigen Skin Test Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Antigen Skin Test Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Antigen Skin Test Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Clinics Image Figure 15. Global Antigen Skin Test Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Antigen Skin Test Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Antigen Skin Test Sales Value Share by Application (2021-2032) Figure 18. Global Antigen Skin Test Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Antigen Skin Test Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Antigen Skin Test Sales Value (2021-2032) & (US$ Million) Figure 21. North America Antigen Skin Test Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Antigen Skin Test Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Antigen Skin Test Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Antigen Skin Test Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Antigen Skin Test Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Antigen Skin Test Sales Value (2021-2032) & (US$ Million) Figure 27. South America Antigen Skin Test Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Antigen Skin Test Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Antigen Skin Test Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Antigen Skin Test Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Antigen Skin Test Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Antigen Skin Test Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Fungal Infection
  • Bacterial Infection
  • Parasitic Infection
Applications
  • Hospitals
  • Clinics
Companies covered
  • BD
  • CorisBioconcept
  • Armed Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antigen Skin Test Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antigen Skin Test Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Antigen Skin Test Market Dynamics
  1. 2.1 Antigen Skin Test Industry Trends
  2. 2.2 Antigen Skin Test Industry Drivers
  3. 2.3 Antigen Skin Test Industry Opportunities and Challenges
  4. 2.4 Antigen Skin Test Industry Restraints
3 Antigen Skin Test Market by Company
  1. 3.1 Global Antigen Skin Test Company Revenue Ranking in 2025
  2. 3.2 Global Antigen Skin Test Revenue by Company (2021-2026)
  3. 3.3 Global Antigen Skin Test Company Ranking (2024-2026)
  4. 3.4 Global Antigen Skin Test Company Manufacturing Base and Headquarters
  5. 3.5 Global Antigen Skin Test Company Product Type and Application
  6. 3.6 Global Antigen Skin Test Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Antigen Skin Test Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Antigen Skin Test Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Antigen Skin Test Market by Type
  1. 4.1 Antigen Skin Test Type Introduction
  2. 4.1.1 Fungal Infection
  3. 4.1.2 Bacterial Infection
  4. 4.1.3 Parasitic Infection
  5. 4.2 Global Antigen Skin Test Sales Value by Type
  6. 4.2.1 Global Antigen Skin Test Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Antigen Skin Test Sales Value by Type (2021-2032)
  8. 4.2.3 Global Antigen Skin Test Sales Value Share by Type (2021-2032)
5 Antigen Skin Test Market by Application
  1. 5.1 Antigen Skin Test Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Antigen Skin Test Sales Value by Application
  5. 5.2.1 Global Antigen Skin Test Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Antigen Skin Test Sales Value by Application (2021-2032)
  7. 5.2.3 Global Antigen Skin Test Sales Value Share by Application (2021-2032)
6 Antigen Skin Test Regional Value Analysis
  1. 6.1 Global Antigen Skin Test Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antigen Skin Test Sales Value by Region (2021-2032)
  3. 6.2.1 Global Antigen Skin Test Sales Value by Region: 2021-2026
  4. 6.2.2 Global Antigen Skin Test Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antigen Skin Test Sales Value (2021-2032)
  7. 6.3.2 North America Antigen Skin Test Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Antigen Skin Test Sales Value (2021-2032)
  10. 6.4.2 Europe Antigen Skin Test Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Antigen Skin Test Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Antigen Skin Test Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Antigen Skin Test Sales Value (2021-2032)
  16. 6.6.2 South America Antigen Skin Test Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Antigen Skin Test Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Antigen Skin Test Sales Value Share by Country, 2025 VS 2032
7 Antigen Skin Test Country-level Value Analysis
  1. 7.1 Global Antigen Skin Test Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antigen Skin Test Sales Value by Country (2021-2032)
  3. 7.2.1 Global Antigen Skin Test Sales Value by Country (2021-2026)
  4. 7.2.2 Global Antigen Skin Test Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Antigen Skin Test Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Antigen Skin Test Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Antigen Skin Test Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Antigen Skin Test Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Antigen Skin Test Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Antigen Skin Test Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Antigen Skin Test Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Antigen Skin Test Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Antigen Skin Test Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Antigen Skin Test Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Antigen Skin Test Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Antigen Skin Test Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Antigen Skin Test Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Antigen Skin Test Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Antigen Skin Test Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Antigen Skin Test Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Antigen Skin Test Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Antigen Skin Test Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Antigen Skin Test Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Antigen Skin Test Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Antigen Skin Test Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Antigen Skin Test Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Antigen Skin Test Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Antigen Skin Test Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Antigen Skin Test Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Antigen Skin Test Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Antigen Skin Test Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Antigen Skin Test Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Antigen Skin Test Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Antigen Skin Test Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BD
  2. 8.1.1 BD Company Information
  3. 8.1.2 BD Business Overview
  4. 8.1.3 BD Antigen Skin Test Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BD Antigen Skin Test Product Portfolio
  6. 8.1.5 BD Recent Developments
  7. 8.2 CorisBioconcept
  8. 8.2.1 CorisBioconcept Company Information
  9. 8.2.2 CorisBioconcept Business Overview
  10. 8.2.3 CorisBioconcept Antigen Skin Test Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CorisBioconcept Antigen Skin Test Product Portfolio
  12. 8.2.5 CorisBioconcept Recent Developments
  13. 8.3 Armed Group
  14. 8.3.1 Armed Group Company Information
  15. 8.3.2 Armed Group Business Overview
  16. 8.3.3 Armed Group Antigen Skin Test Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Armed Group Antigen Skin Test Product Portfolio
  18. 8.3.5 Armed Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research